High-Frequency ChestWallOscillation Devices Health Evidence Review Commission (HERC) Coverage Guidance: High-Frequency ChestWallOscillation Devices Approved 8/11/2022 HERC Coverage Guidance High-frequency chestwalloscillation devices are recommended for coverage for patients with cystic fibrosis (weak recommendation) when there is documentation of frequent exacerbations requiring antibiotic therapy, AND C) The patient has received mucolytics and less costly airway clearance treatments (for example, chest physiotherapy, positive expiratory pressure therapy, self-management techniques) OR such therapies are not tolerated, contraindicated, not effective, or not available (for example, inability of a caregiver to perform chest physiotherapy). High-frequency chestwalloscillation
The Vest for delivering high-frequency chestwalloscillation in people with complex neurological needs The Vest for delivering high-frequency chestwalloscillation in people with complex neurological needs Medtech innovation briefing Published: 14 September 2018 www.nice.org.uk/guidance/mib159 pathwaysSummary Summary • The technologytechnology described in this briefing is The Vest . It is intended to deliver high-frequency chestwalloscillation for clearing airways. The focus of this briefing is its use in adults and children with complex neurological needs, such as cerebral palsy and motor neurone disease (also known as amyotrophic lateral sclerosis). • The innovative aspectsinnovative aspects are that it delivers therapy in a more standardised and consistent way compared with manual
Efficacy of high-frequency chestwalloscillations vs. lung flute in chronic obstructive pulmonary disease patients with post-COVID. In chronic obstructive pulmonary disease (COPD), high-frequency chestwalloscillations (HFCWO) and lung flute (LF) are used to improve COPD patients' pulmonary functions, exertional dyspnea, as well as life quality. This comparative study aimed to assess
Efficacy and Safety Analysis of Piperacillin Tazobactam in Combination With High Frequency ChestWallOscillation in Patients With COPD Coupled With Pneumonia. Chronic obstructive pulmonary disease (COPD) is a common, chronic inflammatory disease of the airway, and acute exacerbation of COPD (AE-COPD) refers to the manifestations of inflammation in the lungs that appear within a short period of time. Some patients contract pneumonia, and they can be prone to recurrent attacks of AE-COPD combined with pneumonia. The efficacy of conventional treatments isn't generally satisfactory. The study intended to investigate the effectiveness and safety of piperacillin tazobactam in combination with the use of high-frequency chest-walloscillation (HFCWO) to produce expectoration for the treatment
High-frequency chestwalloscillation multiple times daily can better reduce the loss of pulmonary surfactant and improve lung compliance in mechanically ventilated patients. High-frequency chestwalloscillation (HFCWO) has been widely recognized for its airway secretion clearance effectiveness in critically ill ICU patients. The purpose of this randomized controlled trial is to validate
Effects of High-Frequency ChestWallOscillation Expectoration System on Pulmonary Rehabilitation and Cortisol Function in Patients with Severe AECOPD. To investigate the effect of high-frequency chest wall oscillatory expectoration system (HFCWO) on pulmonary rehabilitation and cortisol function in patients with severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The 65
Does High-Frequency ChestWallOscillation Have an Impact on Improving Pulmonary Function in Patients With Smoke Inhalation Injury? Smoke inhalation results in bronchospasm of the trachea, increasing secretion of mucus, casts formation, and improvement of blood flow of the airway. High frequency chestwalloscillation is a common modality used for clearing mucus secretion in patients suffering from hypersecretion of thick mucus and used also to help cough clearance. This study aimed to detect the effect of high frequency chestwalloscillation in improving pulmonary function in burn patients suffering from smoke inhalation. Sixty smoke inhalation injury patients were randomly distributed into two groups of equal size. Group A: received high frequency chestwalloscillation and conventional
Effectiveness of two high frequency chestwalloscillation techniques in patients with bronchiectasis: a randomized controlled preliminary study. Chest physiotherapy is an important tool in the treatment of bronchiectasis. High frequency chestwalloscillation (HFCWO) is a technique designed to create a global percussion of the lung which moves secretions and probably clears the peripheral
The effectiveness of a mobile high-frequency chestwalloscillation (HFCWO) device for airway clearance. High-frequency chestwalloscillation (HFCWO) is a commonly prescribed airway clearance technique (ACT) for patients whose ability to expectorate sputum is compromised. This study aimed to assess the effectiveness of a newly developed mobile ACT device (mHFCWO-The Monarch Airway Clearance
Safety and effectiveness of the high-frequency chestwalloscillation vs intrapulmonary percussive ventilation in patients with severe COPD Chest physiotherapy is an important tool in the treatment of COPD. Intrapulmonary percussive ventilation (IPV) and high-frequency chestwalloscillation (HFCWO) are techniques designed to create a global percussion of the lung which removes secretions
Instantaneous responses to high-frequency chestwalloscillation in patients with acute pneumonic respiratory failure receiving mechanical ventilation: A randomized controlled study. Endotracheal intubation and prolonged immobilization of patients receiving mechanical ventilation may reduce expectoration function. High-frequency chestwalloscillation (HFCWO) may ameliorate airway secretion
Analysis of High-Frequency ChestWallOscillation (HFCWO) in the Management of COPD: A Systematic Review PROSPERO International prospective register of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information
The Effect of Airway and ChestWallOscillation on Respiratory Functions in COPD Patients in Acute Exacerbation Chronic obstructive pulmonary disease (COPD); It is a common, treatable and preventable disease characterized by progressive and irreversible airflow limitation and has systemic effects with respiratory system involvement. Increased respiratory workload, decreased work . Chronic programs in patients with COPD, physiotherapy applications used in the exacerbation period are recommended, but there are not many studies examining the device technologies used in this area. In this period, devices that provide chestwalloscillation and airway oscillation can be preferred for the symptomatic treatment of increasing cough and sputum complaints. There is no study comparing these two
The Impact of High Frequency ChestWallOscillation on Healthcare Utilization in Patients with Neuromuscular Diseases. People with neuromuscular disease frequently have difficulty clearing pulmonary secretions, which leads to pneumonia and respiratory failure. High-frequency chestwalloscillation (HFCWO) is one intervention used to facilitate secretion clearance. The objective of this study
Comparison of conventional pulmonary rehabilitation and high-frequency chestwalloscillation in primary ciliary dyskinesia. Enhancement of mucociliary clearance by pulmonary rehabilitation (PR) is advocated in primary ciliary dyskinesia (PCD). Our primary aim was to compare the efficacy and safety of postural drainage, percussion and vibration [conventional PR (CPR)], and high frequency chestwalloscillation (HFCWO) by studying change in pulmonary function. Our secondary aim was to evaluate patient preferences regarding the two methods. This was a controlled randomized crossover study. PCD patients between the ages of 7 and 18 years were assigned to two groups, first group performed airway clearance with CPR at hospital for 5 days and after a 2-day washout period HFCWO was applied
INFLUENCE OF HIGH FREQUENCY CHESTWALLOSCILLATION IN HOSPITALIZED PATIENTS WITH COVID-19 INFLUENCE OF HIGH FREQUENCY CHESTWALLOSCILLATION IN HOSPITALIZED PATIENTS WITH COVID-19The purpose of this Interventional study is to investigate the effect of high frequency chestwalloscillation in hospitalized COVID-19 patients on:Inflammatory markers: Netrophil to lymphocyte ratio and CRPHemodynamic Saturation, time needed for Oxygen Weaning, Mortality Rate and Hospital Stay Period.Research Question:Is there a significant effect of high frequency chestwalloscillation (HFCWO) in Hospitalized COVID-19 Patients? Novel coronavirus disease 2019 (COVID-19) infections, declared by the World Health Organization (WHO) as a pandemic, had unprecedented global effects on people's daily activities and way
VICOR Study-High Frequency ChestWallOscillations (HFCWO) in Patients With Acute Respiratory Failure and Hypersecretion The study aims to evaluates if the treatment with HFCWO Via The Vest® Airway Clearance System, in addition to standard care in critically ill patients admitted in the Respiratory Intensive Care Unit for acute respiratory failure or acute on chronic respiratory failure
Effect of high-frequency chestwalloscillation versus chest physiotherapy on lung function after lung transplant. The aim of this study is to compare the effects of chest physiotherapy (CPT) and high-frequency chestwalloscillation (HFCWO) on lung function in lung transplant recipients. Chest physiotherapy and HFCWO are routinely used after lung transplant to attenuate dyspnea, increase
High-Frequency ChestWallOscillation in Prolonged Mechanical Ventilation Patients-a Randomized Controlled Trial. Patients with prolonged mechanical ventilation (PMV) often retain airway secretions, which may be cleared with the assistance of high-frequency chestwalloscillation (HFCWO). This study aimed to determine the effectiveness, safety and tolerance/comfort of HFCWO after extubation
[A study of the value of high frequency chestwalloscillation in patients with acute exacerbation of chronic obstructive pulmonary disease]. To explore the safety and efficacy of high-frequency chestwalloscillation (HFCWO) in invasive mechanical ventilation patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). A prospective, randomized, controlled trial